Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -370,638 | -305,931 | -277,813 | -201,560 | -194,592 |
| Depreciation Amortization | 7,376 | 4,789 | 3,064 | 1,413 | 4,853 |
| Accounts payable and accrued liabilities | 818 | -1,341 | 382 | -666 | 60 |
| Other Working Capital | 121,244 | 81,473 | 59,334 | 2,639 | 73,484 |
| Other Operating Activity | 174,932 | 152,912 | 143,928 | 159,596 | 20,454 |
| Operating Cash Flow | $-66,268 | $-68,098 | $-71,105 | $-38,578 | $-95,741 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -46,811 | -33,442 | -27,662 | -11,478 | -16,357 |
| Net Acquisitions | 620 | 620 | 620 | 620 | N/A |
| Purchase Of Investment | -777,223 | -606,746 | -428,246 | -289,218 | -282,362 |
| Sale Of Investment | 529,270 | 422,920 | 162,525 | 20,450 | 198,596 |
| Investing Cash Flow | $-294,144 | $-216,648 | $-292,763 | $-279,626 | $-100,123 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 767,075 | 744,862 | 423,237 | 261,758 | 3,155 |
| Other Financing Activity | -10,934 | -10,264 | -9,525 | -8,484 | 319,167 |
| Financing Cash Flow | $756,141 | $734,598 | $413,712 | $253,274 | $322,322 |
| Beginning Cash Position | 177,011 | 177,011 | 177,011 | 177,011 | 50,553 |
| End Cash Position | 572,740 | 626,863 | 226,855 | 112,081 | 177,011 |
| Net Cash Flow | $395,729 | $449,852 | $49,844 | $-64,930 | $126,458 |
| Free Cash Flow | |||||
| Operating Cash Flow | -66,268 | -68,098 | -71,105 | -38,578 | -95,741 |
| Capital Expenditure | -46,811 | -33,442 | -27,662 | -11,478 | -16,357 |
| Free Cash Flow | -113,079 | -101,540 | -98,767 | -50,056 | -112,098 |